Wireless health holds the promise of better patient monitoring, compliance with treatment regimes and medication adherence. Now the field is taking a step forward thanks to a recent FDA OK that paves the way for a new category of digital pills designed to tell consumers and their caregivers when they’ve skipped a medication dose.
On July 30, Proteus Digital Health announced FDA had granted de novo clearance for the firm’s ingestible sensor technology. The de novo process is reserved for low-risk devices for which...
